Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionM&t Bank Corp
Latest Disclosed Ownership3,872 shares
Latest Disclosed Value $ 510,097
M&t Bank Corp reports 10.33% decrease in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 12, 2026 - M&t Bank Corp filed a 13F-HR form disclosing ownership of 3,872 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $510,097 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on January 30, 2026 disclosing 4,318 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -10.33% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,872 -446 -10.33 510 -16.67 0.0004
2026-01-30 2025-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 4,318 1,007 30.41 613 31.90 0.0020
2026-01-28 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,980 5,669 711 0.0004
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,311 -1,066 -24.35 465 -15.48 0.0016
2025-08-13 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,377 139 3.28 550 17.31 0.0019
2025-04-30 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,238 -2,740 -39.27 469 -50.84 0.0017
2025-02-06 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,978 1,322 23.37 952 46.24 0.0032
2024-11-19 2024-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 5,656 -342 -5.70 651 -21.09 0.0021
2024-11-15 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,656 -342 651 0.0004
2024-07-31 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,998 -189 -3.05 826 -3.28 0.0028
2024-05-07 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,187 -597 -8.80 854 -4.48 0.0030
2024-02-06 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,784 -443 -6.13 894 9.84 0.0033
2023-11-02 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,227 -2,768 -27.69 814 -13.69 0.0032
2023-08-09 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,995 -496 -4.73 943 -11.30 0.0035
2023-05-11 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,491 -1,184 -10.14 1,063 -23.82 0.0041
2023-02-13 2022-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 11,675 1,529 15.07 1,395 29.31 0.0056
2023-02-13 2022-12-31 13F NETEASE SPONSORED ADS 64125C109 15,490 5,344 1,671 0.0067
2022-11-17 2022-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 10,146 -3,953 -28.04 1,078 266.67 0.0048
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,146 -3,953 1,029 0.0009
2022-08-05 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 14,099 11,456 433.45 294 18.55 0.0014
2022-05-09 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,643 92 3.61 248 13.76 0.0011
2022-02-07 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,551 -294 -10.33 218 -20.44 0.0009
2021-10-28 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,845 -5 -0.18 274 -1.44 0.0012
2021-08-13 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,850 9 0.32 278 0.36 0.0012
2021-05-06 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,841 -163 -5.43 277 -4.15 0.0012
2021-02-12 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,004 -45 -1.48 289 -1.70 0.0013
2020-11-06 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,049 173 6.02 294 -16.24 0.0014
2020-07-29 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,876 -496 -14.71 351 20.62 0.0019
2020-05-14 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,372 59 1.78 291 -18.03 0.0017
2020-02-07 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,313 -168 -4.83 355 13.42 0.0017
2019-11-12 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,481 104 3.08 313 9.44 0.0016
2019-08-12 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,377 153 4.75 286 0.35 0.0015
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,224 232 7.75 285 33.18 0.0015
2019-02-01 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,992 -95 -3.08 214 -43.68 0.0012
2018-11-09 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,087 248 8.74 380 36.69 0.0019
2018-08-10 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,839 13 0.46 278 18.30 0.0015
2018-05-04 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,826 219 8.40 235 16.34 0.0013
2018-02-06 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,607 2,607 202 0.0011
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -7,069 -100.00 0 -100.00
2016-11-04 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,069 2,458 53.31 358 70.48 0.0023
2016-08-04 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,611 -2,042 -30.69 210 -19.85 0.0014
2016-05-11 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,653 6,653 0.00 262 0.0018
2015-11-13 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -6,555 -100.00 0 -100.00
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,555 -219 -3.23 312 15.99 0.0019
2015-05-14 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,774 6,713 11,004.92 269 26,800.00 0.0017
2014-05-14 2014-03-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 61 61 1 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.